Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis

International Journal of Cancer

Volumn 129, Issue 1, 2011, Pages 88-100

  Prakobwong, Suksanti ^a,b   Khoontawad, Jarinya ^a   Yongvanit, Puangrat ^a   Pairojkul, Chawalit ^a   Hiraku, Yusuke ^c   Sithithaworn, Paiboon ^a   Pinlaor, Porntip ^a,d   Aggarwal, Bharat B ^b   Pinlaor, Somchai ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF TEXAS   (United States)

^c MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KHON KAEN UNIVERSITY   (Thailand)

Author keywords

angiogenesis; apoptosis; cell proliferation; cholangiocarcinoma; curcumin; DNA damage; Opisthorchis viverrini

Indexed keywords

CURCUMIN; CYCLOOXYGENASE 2; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN C FOS; STAT3 PROTEIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFICACY; GROWTH INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE; TRANSCRIPTION INITIATION; TREATMENT RESPONSE; UPREGULATION;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BASE SEQUENCE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHOLANGIOCARCINOMA; CRICETINAE; CURCUMIN; DEOXYRIBONUCLEOTIDES; DIET; ELECTROPHORETIC MOBILITY SHIFT ASSAY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MESOCRICETUS; NF-KAPPA B;

EID: 79955454533     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25656     Document Type: Article

References (49)

1. McLean L, Patel T,. Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver Int 2006; 26: 1047-53. (Pubitemid 44541745)
2. Sripa B, Pairojkul C,. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 2008; 24: 349-56. (Pubitemid 351535894)
3. Vatanasapt V, Martin N, Sriplung H, Chindavijak K, Sontipong S, Sriamporn H, Parkin DM, Ferlay J,. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev 1995; 4: 475-83.
4. Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM,. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, Northeast Thailand. Trop Med Int Health 2004; 9: 588-94. (Pubitemid 38657284)
5. Thamavit W, Bhamarapravati N, Sahaphong S, Vajrasthira S, Angsubhakorn S,. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res 1978; 38: 4634-9. (Pubitemid 9065143)
6. Ohshima H, Bandaletova TY, Brouet I, Bartsch H, Kirby G, Ogunbiyi F, Vatanasapt V, Pipitgool V,. Increased nitrosamine and nitrate biosynthesis mediated by nitric oxide synthase induced in hamsters infected with liver fluke (Opisthorchis viverrini). Carcinogenesis 1994; 15: 271-5. (Pubitemid 24121660)
7. Pinlaor S, Ma N, Hiraku Y, Yongvanit P, Semba R, Oikawa S, Murata M, Sripa B, Sithithaworn P, Kawanishi S,. Repeated infection with Opisthorchis viverrini induces accumulation of 8-nitroguanine and 8-oxo-7,8-dihydro-2′- deoxyguanine in the bile duct of hamsters via inducible nitric oxide synthase. Carcinogenesis 2004; 25: 1535-42. (Pubitemid 39162719)
8. Pinlaor S, Sripa B, Ma N, Hiraku Y, Yongvanit P, Wongkham S, Pairojkul C, Bhudhisawasdi V, Oikawa S, Murata M, Semba R, Kawanishi S,. Nitrative and oxidative DNA damage in intrahepatic cholangiocarcinoma patients in relation to tumor invasion. World J Gastroenterol 2005; 11: 4644-9. (Pubitemid 41179516)
9. Patel T, Singh P,. Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol 2007; 23: 317-23. (Pubitemid 46573149)
10. Anderson C, Kim R,. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions. Cancer Treat Rev 2009; 35: 322-7.
11. Darnell JE, Jr,. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002; 2: 740-9. (Pubitemid 37328909)
12. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y,. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461-6. (Pubitemid 39329586)
13. Karin M,. Nuclear factor-κB in cancer development and progression. Nature 2006; 441: 431-6. (Pubitemid 44050137)
14. Aggarwal BB,. Nuclear factor-κB: the enemy within. Cancer Cell 2004; 6: 203-8.
15. Pinlaor S, Hiraku Y, Ma N, Yongvanit P, Semba R, Oikawa S, Murata M, Sripa B, Sithithaworn P, Kawanishi S,. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide 2004; 11: 175-83. (Pubitemid 39371095)
16. Aggarwal BB, Shishodia S,. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006; 71: 1397-421.
17. Pinlaor S, Yongvanit P, Prakobwong S, Kaewsamut B, Khoontawad J, Pinlaor P, Hiraku Y,. Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant-antioxidant status in hamsters infected with Opisthorchis viverrini. Mol Nutr Food Res 2009; 53: 1316-28.
18. Pinlaor S, Prakobwong S, Hiraku Y, Pinlaor P, Laothong U, Yongvanit P,. Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment. Eur J Pharmacol 2010; 638: 134-41.
19. Gescher AJ, Sharma RA, Steward WP,. Cancer chemoprevention by dietary constituents: a tale of failure and promise. Lancet Oncol 2001; 2: 371-9. (Pubitemid 33585942)
20. Prakobwong S, Pinlaor S, Yongvanit P, Sithithaworn P, Pairojkul C, Hiraku Y,. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Int J Parasitol 2009; 39: 825-35.
21. Singh S, Aggarwal BB,. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995; 270: 24995-5000.
22. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB,. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation. Mol Pharmacol 2006; 69: 195-206. (Pubitemid 43048906)
23. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP,. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56-65. (Pubitemid 40385505)
24. Prakobwong S, Yongvanit P, Hiraku Y, Pairojkul C, Sithithaworn P, Pinlaor P, Pinlaor S,. Involvement of MMP-9 in peribiliary fibrosis and cholangiocarcinogenesis via Rac1 dependent DNA damage in a hamster model. Int J Cancer 2010; 127: 2576-87.
25. Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, Farrow S, Howells L,. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex. Oncogene 1999; 18: 6013-20. (Pubitemid 29535013)
26. Chun KS, Keum YS, Han SS, Song YS, Kim SH, Surh YJ,. Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-κB activation. Carcinogenesis 2003; 24: 1515-24. (Pubitemid 37160842)
27. Han SS, Keum YS, Seo HJ, Surh YJ,. Curcumin suppresses activation of NF-κB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 2002; 35: 337-42.
28. Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, Guha S, Krishnan S, Aggarwal BB,. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 2009; 125: 2187-97.
29. Bharti AC, Shishodia S, Reuben JM, Weber D, Alexanian R, Raj-Vadhan S, Estrov Z, Talpaz M, Aggarwal BB,. Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 2004; 103: 3175-84. (Pubitemid 38451696)
30. Kim YS, Ahn Y, Hong MH, Joo SY, Kim KH, Sohn IS, Park HW, Hong YJ, Kim JH, Kim W, Jeong MH, Cho JG, et al. Curcumin attenuates inflammatory responses of TNF-α-stimulated human endothelial cells. J Cardiovasc Pharmacol 2007; 50: 41-9. (Pubitemid 47220445)
31. Chadalapaka G, Jutooru I, Chintharlapalli S, Papineni S, Smith R, III, Li X, Safe S,. Curcumin decreases specificity protein expression in bladder cancer cells. Cancer Res 2008; 68: 5345-54.
32. Taniai M, Grambihler A, Higuchi H, Werneburg N, Bronk SF, Farrugia DJ, Kaufmann SH, Gores GJ,. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Res 2004; 64: 3517-24. (Pubitemid 38657926)
33. Isomoto H, Mott JL, Kobayashi S, Werneburg NW, Bronk SF, Haan S, Gores GJ,. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing. Gastroenterology 2007; 132: 384-96. (Pubitemid 46108750)
34. Blechacz BR, Smoot RL, Bronk SF, Werneburg NW, Sirica AE, Gores GJ,. Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2. Hepatology 2009; 50: 1861-70.
35. Sripa B, Mairiang E, Thinkhamrop B, Laha T, Kaewkes S, Sithithaworn P, Tessana S, Loukas A, Brindley PJ, Bethony JM,. Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6. Hepatology 2009; 50: 1273-81.
36. Ishimura N, Bronk SF, Gores GJ,. Inducible nitric oxide synthase up-regulates Notch-1 in mouse cholangiocytes: implications for carcinogenesis. Gastroenterology 2005; 128: 1354-68. (Pubitemid 40712185)
37. Kobayashi S, Werneburg NW, Bronk SF, Kaufmann SH, Gores GJ,. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Gastroenterology 2005; 128: 2054-65. (Pubitemid 40824713)
38. Sahu RP, Batra S, Srivastava SK,. Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells. Br J Cancer 2009; 100: 1425-33.
39. Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, Luo DZ, Mo WG, Fukui Y, Kawanishi S,. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Int J Cancer 2008; 122: 2517-25. (Pubitemid 351590485)
40. Jinawath N, Chamgramol Y, Furukawa Y, Obama K, Tsunoda T, Sripa B, Pairojkul C, Nakamura Y,. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma. Hepatology 2006; 44: 1025-38. (Pubitemid 46489566)
41. Valdembri D, Serini G, Vacca A, Ribatti D, Bussolino F,. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J 2002; 16: 225-7.
42. Leo E, Deveraux QL, Buchholtz C, Welsh K, Matsuzawa S, Stennicke HR, Salvesen GS, Reed JC,. TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-α-induced apoptosis. J Biol Chem 2001; 276: 8087-93.
43. Fotin-Mleczek M, Henkler F, Hausser A, Glauner H, Samel D, Graness A, Scheurich P, Mauri D, Wajant H,. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-κB activation. J Biol Chem 2004; 279: 677-85. (Pubitemid 38044872)
44. Wang X, Wang Q, Hu W, Evers BM,. Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-κB- dependent pathway. Oncogene 2004; 23: 1885-95. (Pubitemid 38445414)
45. Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, Geller DA,. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-κB activation in cancer cells. Cancer Res 2009; 69: 3764-71.
46. Magalhaes LG, Machado CB, Morais ER, Moreira EB, Soares CS, da Silva SH, Da Silva Filho AA, Rodrigues V,. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol Res 2009; 104: 1197-201.
47. Chuang SE, Cheng AL, Lin JK, Kuo ML,. Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol 2000; 38: 991-5.
48. Goel A, Kunnumakkara AB, Aggarwal BB,. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008; 75: 787-809.
49. Suphim B, Prawan A, Kukongviriyapan U, Kongpetch S, Buranrat B, Kukongviriyapan V,. Redox modulation and human bile duct cancer inhibition by curcumin. Food Chem Toxicol 2010; 48: 2265-72.